{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:01:41Z","timestamp":1794358901389,"version":"4.9.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy & Infectious Diseases of the National Institutes of Health"},{"name":"R01AI051334"},{"name":"R01AI42143"},{"name":"R01AI63940"},{"name":"Canadian Institutes of Health Research"},{"name":"Michael Smith Foundation for Health Research"},{"name":"Washington Life Sciences Discovery Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.09.053","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T14:45:24Z","timestamp":1381761924000},"page":"1602-1609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Current status of syphilis vaccine development: Need, challenges, prospects"],"prefix":"10.1016","volume":"32","author":[{"given":"Caroline E.","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila A.","family":"Lukehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.09.053_bib0005","series-title":"Prevalence and incidence of selected sexually transmitted infections Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0010","series-title":"Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. 2001","author":"World Health Organization","year":"2013"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0015","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.7189\/jogh.01.010402","article-title":"An estimate of syphilis incidence in Eastern Europe","volume":"2","author":"Herbert","year":"2012","journal-title":"J Glob Health"},{"issue":"47","key":"10.1016\/j.vaccine.2013.09.053_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.14.47.19417-en","article-title":"Syphilis and gonorrhoea in men who have sex with men: a European overview","volume":"14","author":"Savage","year":"2009","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.olq.0000149848.03733.c1","article-title":"The re-emergence of syphilis in the United Kingdom: the new epidemic phases","volume":"32","author":"Simms","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"29","key":"10.1016\/j.vaccine.2013.09.053_bib0030","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.29.20224-en","article-title":"Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011","volume":"17","author":"Savage","year":"2012","journal-title":"Euro Surveill"},{"issue":"9791","key":"10.1016\/j.vaccine.2013.09.053_bib0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(11)61274-9","article-title":"Syphilis on the rise in the USA","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0040","series-title":"Sexually Transmitted Disease Surveillance 2009","author":"Centers for Disease Control and Prevention","year":"2010"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2013.09.053_bib0045","first-page":"1","article-title":"Canadian sexually transmitted infections surveillance report","volume":"33","year":"2007","journal-title":"Can Commun Dis Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1467-842X.2006.tb00781.x","article-title":"Epidemic infectious syphilis in inner Sydney \u2013 strengthening enhanced surveillance","volume":"30","author":"Botham","year":"2006","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1467-842X.2005.tb00215.x","article-title":"The re-emergence of syphilis among homosexually active men in Melbourne","volume":"29","author":"Lee","year":"2005","journal-title":"Aust N Z J Public Health"},{"issue":"1211","key":"10.1016\/j.vaccine.2013.09.053_bib0060","first-page":"U1349","article-title":"Is syphilis resurgent in New Zealand in the 21st century? A case series of infectious syphilis presenting to the Auckland Sexual Health Service","volume":"118","author":"Azariah","year":"2005","journal-title":"N Z Med J"},{"issue":"18","key":"10.1016\/j.vaccine.2013.09.053_bib0065","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJMp0911149","article-title":"Syphilis and social upheaval in China","volume":"362","author":"Tucker","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/QCO.0b013e32834204bf","article-title":"China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses","volume":"24","author":"Tucker","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.09.053_bib0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/S0002-9378(03)00470-8","article-title":"The infectious origins of stillbirth","volume":"189","author":"Goldenberg","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.09.053_bib0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/342952","article-title":"Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy","volume":"186","author":"Watson-Jones","year":"2002","journal-title":"J Infect Dis"},{"issue":"9859","key":"10.1016\/j.vaccine.2013.09.053_bib0085","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.070495","article-title":"Resurgence of early congenital syphilis in Alberta","volume":"177","author":"Singh","year":"2007","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0095","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1371\/journal.pntd.0000256","article-title":"Neglected infections of poverty in the United States of America","volume":"2","author":"Hotez","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.09.053_bib0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.2009.143","article-title":"Penicillin treatment of syphilis: clearing away the shadow on the land","volume":"301","author":"Douglas","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0105","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/01.qai.0000127062.94627.31","article-title":"Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV\/sexually transmitted disease intervention trials?: A modeling study","volume":"37","author":"White","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"RR-12","key":"10.1016\/j.vaccine.2013.09.053_bib0110","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2013.09.053_bib0115","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1172\/JCI57173","article-title":"Syphilis: using modern approaches to understand an old disease","volume":"121","author":"Ho","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0120","unstructured":"Centers for Disease Control and Prevention, 2000, http:\/\/www.cdc.gov\/stopsyphilis [accessed 05.03.13]."},{"key":"10.1016\/j.vaccine.2013.09.053_bib0125","series-title":"The national plan to eliminate syphilis from the United States","author":"Centers for Disease Control and Prevention","year":"2006"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0130","series-title":"The global elimination of congenital syphilis: rationale and strategy for action","author":"World Health Organization","year":"2007"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0135","first-page":"283","article-title":"Diagnosis and management of syphilis","volume":"68","author":"Brown","year":"2003","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0140","first-page":"138","article-title":"Sexually transmitted infections and HIV: epidemiology and interventions","volume":"18","author":"Celum","year":"2010","journal-title":"Top HIV Med"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/sti.2006.022467","article-title":"Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis","volume":"82","author":"Mabey","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0150","doi-asserted-by":"crossref","first-page":"e1001396","DOI":"10.1371\/journal.pmed.1001396","article-title":"Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data","volume":"10","author":"Newman","year":"2013","journal-title":"PLoS Med"},{"issue":"15","key":"10.1016\/j.vaccine.2013.09.053_bib0155","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/00002030-199910220-00015","article-title":"Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team","volume":"13","author":"Gray","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.genet.36.041602.134359","article-title":"Genetics of motility and chemotaxis of a fascinating group of bacteria: the spirochetes","volume":"36","author":"Charon","year":"2002","journal-title":"Annu Rev Genet"},{"issue":"5375","key":"10.1016\/j.vaccine.2013.09.053_bib0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.281.5375.375","article-title":"Complete genome sequence of Treponema pallidum, the syphilis spirochete","volume":"281","author":"Fraser","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0170","doi-asserted-by":"crossref","first-page":"e1471","DOI":"10.1371\/journal.pntd.0001471","article-title":"Whole genome sequences of three Treponema palidum ssp. pertenue strains: yaws and syphilis treponemes differ in less than 0.2% of the genome sequence","volume":"6","author":"Cejko\u00e1","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0966-842X(98)01422-X","article-title":"Treponema pallidum: doing a remarkable job with what it's got","volume":"7","author":"Radolf","year":"1999","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.19.1.29-49.2006","article-title":"Biological basis for syphilis","volume":"19","author":"LaFond","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2013.09.053_bib0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-109-11-855","article-title":"Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment","volume":"109","author":"Lukehart","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.1937.01470240093008","article-title":"Rapidity with which Spirochaeta pallida invades the bloodstream","volume":"35","author":"Raiziss","year":"1937","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0195","first-page":"201","article-title":"Rate of multiplication of Treponema pallidum in normal and immune rabbits","volume":"33","author":"Cumberland","year":"1949","journal-title":"Am J Syph"},{"issue":"8","key":"10.1016\/j.vaccine.2013.09.053_bib0200","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/IAI.57.8.2267-2271.1989","article-title":"In vitro model of Treponema pallidum invasiveness","volume":"57","author":"Riviere","year":"1989","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2013.09.053_bib0205","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1073\/pnas.85.10.3608","article-title":"Treponema pallidum invades intercellular junctions of endothelial cell monolayers","volume":"85","author":"Thomas","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0210","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1128\/IAI.01424-07","article-title":"A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin","volume":"76","author":"Brinkman","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0215","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1128\/JB.186.20.7019-7022.2004","article-title":"Treponema pallidum fibronectin-binding proteins","volume":"186","author":"Cameron","year":"2004","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0220","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/IAI.71.5.2525-2533.2003","article-title":"Identification of a Treponema pallidum laminin-binding protein","volume":"71","author":"Cameron","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0225","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1128\/IAI.73.11.7485-7494.2005","article-title":"Defining the interaction of the Treponema pallidum adhesin Tp0751 with laminin","volume":"73","author":"Cameron","year":"2005","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2013.09.053_bib0230","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JB.01537-07","article-title":"Heterologous expression of the Treponema pallidum laminin-binding adhesin Tp0751 in the culturable spirochete Treponema phagedenis","volume":"190","author":"Cameron","year":"2008","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.09.053_bib0235","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/IAI.01083-10","article-title":"Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751","volume":"79","author":"Houston","year":"2011","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2013.09.053_bib0240","doi-asserted-by":"crossref","first-page":"e1002822","DOI":"10.1371\/journal.ppat.1002822","article-title":"Activation and proteolytic activity of the Treponema pallidum metalloprotease, pallilysin","volume":"8","author":"Houston","year":"2012","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4049\/jimmunol.124.1.461","article-title":"Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and Treponema pallidum distribution in testicular lesions","volume":"124","author":"Lukehart","year":"1980","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.09.053_bib0250","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/IAI.64.3.1048-1050.1996","article-title":"Lesions of primary and secondary syphilis contain activated cytolytic T cells","volume":"64","author":"Van Voorhis","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0255","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1086\/511822","article-title":"Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis","volume":"195","author":"Salazar","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0260","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2353\/ajpath.2010.100277","article-title":"Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-\/IL-17-producing CD8+ T cells?","volume":"177","author":"Stary","year":"2010","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/infdis\/165.1.69","article-title":"Macrophage-mediated killing of opsonized Treponema pallidum","volume":"165","author":"Baker-Zander","year":"1992","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0270","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/infdis\/166.6.1449","article-title":"A subpopulation of Treponema pallidum is resistant to phagocytosis: possible mechanism of persistence","volume":"166","author":"Lukehart","year":"1992","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.09.053_bib0275","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0022-5193(72)90012-4","article-title":"The immunoprotective niche \u2013 a new pathogenic mechanism for syphilis, the systemic mycoses and other infectious diseases","volume":"36","author":"Medici","year":"1972","journal-title":"J Theor Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2013.09.053_bib0280","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/jb.171.9.5005-5011.1989","article-title":"Demonstration of rare protein in the outer membrane of Treponema pallidum subsp. pallidum by freeze-fracture analysis","volume":"171","author":"Walker","year":"1989","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0285","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1073\/pnas.86.6.2051","article-title":"Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum","volume":"86","author":"Radolf","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0290","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jmb.2010.09.020","article-title":"Cellular architecture of Treponema pallidum: novel flagellum, periplasmic cone, and cell envelope as revealed by cryo electron tomography","volume":"403","author":"Liu","year":"2010","journal-title":"J Mol Biol"},{"issue":"24","key":"10.1016\/j.vaccine.2013.09.053_bib0295","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1128\/JB.01031-09","article-title":"Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete","volume":"191","author":"Izard","year":"2009","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2958.1995.tb02332.x","article-title":"Treponema pallidum and the quest for outer membrane proteins","volume":"16","author":"Radolf","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0305","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.189.4.647","article-title":"Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response","volume":"189","author":"Centurion-Lara","year":"1999","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2013.09.053_bib0310","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JB.00101-12","article-title":"TprC\/D (Tp0117\/131), a trimeric, pore-forming rare outer membrane protein of Treponema pallidum, has a bipartite domain structure","volume":"194","author":"Anand","year":"2012","journal-title":"J Bacteriol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.09.053_bib0315","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.0902788","article-title":"Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis","volume":"184","author":"Giacani","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1574-695X.2007.00303.x","article-title":"Length of guanosine homopolymeric repeats modulates promoter activity of subfamily II tpr genes of Treponema pallidum ssp. pallidum","volume":"51","author":"Giacani","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0325","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/IAI.68.2.824-831.2000","article-title":"The tprK gene is heterogeneous among Treponema pallidum strains and has multiple alleles","volume":"68","author":"Centurion-Lara","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0330","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1365-2958.2004.04086.x","article-title":"Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection","volume":"52","author":"Centurion-Lara","year":"2004","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.09.053_bib0335","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/IAI.00827-06","article-title":"Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis","volume":"74","author":"LaFond","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0340","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1371\/journal.pntd.0002222","article-title":"Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains","volume":"7","author":"Centurion-Lara","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.09.053_bib0345","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1128\/IAI.00834-10","article-title":"Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum","volume":"78","author":"Cox","year":"2010","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0350","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1365-2958.2011.07662.x","article-title":"TP0326, a Treponema pallidum beta-barrel assembly machinery A (BamA) orthologue and rare outer membrane protein","volume":"80","author":"Desrosiers","year":"2011","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0355","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/315399","article-title":"Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92","volume":"181","author":"Cameron","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.09.053_bib0360","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.micinf.2004.04.001","article-title":"I Treponema pallidum repeat protein family: sequence variation and immunity","volume":"6","author":"Sun","year":"2004","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/426510","article-title":"Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model","volume":"191","author":"Tantalo","year":"2005","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2013.09.053_bib0370","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1139\/m85-142","article-title":"Experimental congenital syphilis in rabbits","volume":"31","author":"Fitzgerald","year":"1985","journal-title":"Can J Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.04.002","article-title":"Quantitation of rabbit cytokine mRNA by real-time RT-PCR","volume":"38","author":"Godornes","year":"2007","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0380","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by \u03b3-irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0385","first-page":"267","article-title":"Attempted immunization of rabbits against syphilis with killed Treponema pallidum and adjuvants","volume":"28","author":"Magnuson","year":"1947","journal-title":"J Vener Dis Inf"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0390","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1084\/jem.87.5.369","article-title":"The antibody response in rabbits to killed suspensions of pathogenic Treponema pallidum","volume":"87","author":"Eagle","year":"1948","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0395","first-page":"568","article-title":"Further attempts to immunize rabbits with killed Treponema pallidum","volume":"35","author":"Waring","year":"1951","journal-title":"Am J Syph Gonorrhea Vener Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0400","first-page":"9","article-title":"Production of immobilizing antibodies unaccompanied by active immunity to Treponema pallidum as shown by injecting rabbits and mice with the killed organisms","volume":"37","author":"McLeod","year":"1953","journal-title":"Am J Syph Gonorrhea Vener Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0405","first-page":"431","article-title":"Antigenicity in rabbits and relation to immunity","volume":"77","author":"McLeod","year":"1962","journal-title":"Public Health Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2340\/0001555551157160","article-title":"Resistance and serological changes in rabbits immunized with virulent Treponema pallidum sonicate","volume":"51","author":"Izzat","year":"1971","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.09.053_bib0415","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/clinids\/7-Supplement_2.S305","article-title":"Prospects for development of a treponemal vaccine","volume":"7","author":"Lukehart","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/14760584.5.1.67","article-title":"Progress towards an effective syphilis vaccine: the past, present and future","volume":"5","author":"Cullen","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0425","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/167.5.1100","article-title":"VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages","volume":"167","author":"Baker-Zander","year":"1993","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0430","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/IAI.73.5.3083-3095.2005","article-title":"A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum","volume":"73","author":"Blanco","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0435","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.44.5.589","article-title":"On variations in the response of treated rabbits to reinoculation; and on cryptogenic reinfection with syphilis","volume":"44","author":"Chesney","year":"1926","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2013.09.053_bib0440","first-page":"418","article-title":"The rate of development and degree of acquired immunity in experimental syphilis","volume":"32","author":"Magnuson","year":"1948","journal-title":"Am J Syph Gonorrhea Vener Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.09.053_bib0445","first-page":"297","article-title":"The duration of acquired immunity in experimental syphilis","volume":"33","author":"Magnuson","year":"1949","journal-title":"Am J Syph Gonorrhea Vener Dis"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0450","first-page":"112","article-title":"The relationship of treponemal immobilizing antibody to immunity in syphilis","volume":"63","author":"Turner","year":"1950","journal-title":"Trans Assoc Am Physicians"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.117.1.191","article-title":"Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization","volume":"117","author":"Bishop","year":"1976","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.09.053_bib0460","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/140.3.378","article-title":"Endemic syphilis: passive transfer of resistance with serum and cells in hamsters","volume":"140","author":"Schell","year":"1979","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.09.053_bib0465","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1128\/IAI.70.12.6811-6816.2002","article-title":"Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model","volume":"70","author":"Morgan","year":"2002","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2013.09.053_bib0470","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1128\/IAI.66.12.5763-5770.1998","article-title":"Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase","volume":"66","author":"Cameron","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2013.09.053_bib0475","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00005792-195602000-00002","article-title":"Inoculation syphilis in human volunteers","volume":"35","author":"Magnuson","year":"1956","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0480","series-title":"Biology of the Treponematoses","author":"Turner","year":"1957"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0485","first-page":"25","article-title":"How the research-based industry approaches vaccine development and establishes priorities","volume":"110","author":"Andre","year":"2002","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0490","unstructured":"Bill Melinda Gates Foundation Global health leaders launch Decade of Vaccines collaboration. 2010 Feb 12."},{"issue":"15","key":"10.1016\/j.vaccine.2013.09.053_bib0495","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1359-6446(05)03533-6","article-title":"How can we avoid the productivity gap?","volume":"10","author":"Carney","year":"2005","journal-title":"Drug Discov Today"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.09.053_bib0500","doi-asserted-by":"crossref","first-page":"B184","DOI":"10.1016\/j.vaccine.2012.12.032","article-title":"Delivering the promise of the decade of vaccines: opportunities and challenges in the development of high quality new vaccines","volume":"31","author":"Keith","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2013.09.053_bib0505","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1286-4579(02)01638-6","article-title":"The immune response to infection with Treponema pallidum, the stealth pathogen","volume":"4","author":"Salazar","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-7185-2_1","article-title":"The value of vaccination","volume":"697","author":"Bloom","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.09.053_bib0515","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/IAI.73.6.3817-3822.2005","article-title":"Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum","volume":"73","author":"Giacani","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.053_bib0520","series-title":"The Pathogenic Spirochetes: Strategies for Evasion of Host Immunity and Persistence","article-title":"Treponema pallidum dissemination; facilitating immune evasion and bacterial persistence","author":"Houston","year":"2012"},{"issue":"24","key":"10.1016\/j.vaccine.2013.09.053_bib0525","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1128\/JB.01494-12","article-title":"Biophysical and bioinformatic analyses implicate the Treponema pallidum Tp34 lipoprotein (Tp0971) in transition metal homeostasis","volume":"194","author":"Brautigam","year":"2012","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T17:42:45Z","timestamp":1716054165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13013169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":105,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13013169"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of syphilis vaccine development: Need, challenges, prospects","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}